AG1
D2C nutrition brand selling a daily greens supplement.
Available information varies by company and source.
Profile record updated:
Company facts
- Entity type
- COMPANY
- Founded
- 2010
- Headquarters
- 3064 Silver Sage Dr STE 150, Carson City, NV 89701
- Company size
- 501–1,000
- Market role
- Advertiser / Brand
- Official website
- drinkag1.com
What AG1 does
AG1 operates as a consumer packaged goods brand built around a flagship powdered nutrition product. It creates value by packaging convenience, brand trust and repeat wellness consumption into a subscription-friendly product that can be sold directly online at high frequency. The company captures demand through brand marketing, owned digital commerce and selected retail distribution, then monetises through product sales, repeat orders and wholesale channel expansion.
Category differentiation
AG1 is a consumer nutrition brand selling a powdered daily supplement, not an adtech, martech or enterprise software platform. It is the rebranded successor to Athletic Greens, not a separate retailer or marketplace.
Strategic context
AI-supported assessment from the existing company research; distinguish interpretation from sourced facts.
AG1 is a private direct-to-consumer nutrition company selling a powdered daily health supplement under the AG1 brand. The company was founded in 2010, is headquartered in the United States, and rebranded from Athletic Greens to AG1. Its core commercial activity is selling a flagship daily greens product through its owned e-commerce channels, with additional distribution through authorised retail and marketplace partners. The business makes money by selling physical supplement products via direct online purchases, recurring subscription orders and expanding wholesale retail distribution. Its customer base is health-conscious consumers seeking an all-in-one daily nutrition product rather than enterprise buyers. Recent distribution evidence shows AG1 is extending beyond pure D2C into brick-and-mortar retail, which broadens customer acquisition and diversifies channel exposure.
Company news briefing
Briefing updated:
AG1 has committed $20 million to funding its own clinical research, published in peer-reviewed journals, to support marketing claims and drive product development. This strategic investment aims to combat misinformation, appeal to data-driven consumers, and satisfy wholesale buyers demanding third-party validation. Executives note that this scientific backing serves as a long-term brand investment, resulting in higher-performing advertisements and stronger retail positioning.
Business model & monetisation
AG1 monetises through physical product sales of its daily greens powder. The primary pricing mechanism is direct-to-consumer e-commerce, including recurring subscription purchases and one-off orders. Secondary monetisation comes from authorised third-party retail and marketplace distribution, including wholesale sales through partners such as Costco and Amazon.
- Direct website sales
- Retail Margin
- Recurring subscription orders
- Content Subscription
- Wholesale retail distribution
- Retail Margin
- Authorised marketplace sales
- Retail Margin
Products & capabilities
No products with linked sources are available in this view.
Recent recorded signals
Dates refer to the source publication. Older entries are historical context, not evidence of a new event.
Brands Use Clinical Research as Growth Engine
E-commerce / Brand Strategy · Recorded impact score: 2/5
Supplement and cleaning brands like AG1, Ritual, and Blueland are increasingly funding their own clinical research to differentiate products, boost advertising performance, and gain retail shelf space. These companies conduct or commission studies published in peer-reviewed journals, using findings to support marketing claims and product development. For instance, AG1 committed $20 million to research, while Ritual has invested over $5 million in studies. Such research helps brands combat misinformation, appeal to data-driven consumers, and satisfy wholesale buyers demanding third-party validation. Although there is no official FTC definition of 'clinical,' companies follow guidelines requiring competent scientific evidence for health claims. This strategy serves as a long-term brand investment, with executives noting higher-performing ads and stronger retail positioning as outcomes.
- AG1 committed $20 million to support three years of gut health and nutrient gap research.
- Ritual has invested at least $5 million in clinical studies and employed up to 20 full-time positions for research.
Explore company relationships
Questions about AG1
What is AG1?
AG1 is a private nutrition brand that sells a daily greens supplement in powder form through direct online and retail channels.
Who uses AG1?
AG1 is used by health-conscious consumers who want a convenient all-in-one daily nutrition supplement.
How does AG1 make money?
AG1 makes money by selling supplement products through direct e-commerce, recurring subscriptions, authorised marketplace sales and retail distribution.
Sources & coverage
This profile uses public, official and technically observable information. Missing information does not prove that a product or relationship does not exist. The list below does not imply that every profile statement has been verified.
10 publicly documented primary sources and citations linked across the market graph.
Continue your research on AG1
Explorer includes additional company details, a Watchlist for up to 25 companies and your personal Strategic Intelligence Agent. It monitors your market daily and delivers tailored briefings with clear strategic context whenever relevant news occurs.
Free, with no time limit.